Kaixian Zheng
Fangda Partners - CHINA
Kaixian Zheng 's competencies
| Practice Area | Jurisdiction | Rank | Agg. Deals Value | Clients Dimension | N. of Transactions | Last Quarter |
|---|---|---|---|---|---|---|
| Corporate M&A | CHINA | 10 | 4500 | 1258 | 1 |  |
| Practice Area | Jurisdiction | Rank | Agg. Deals Value | Clients Dimension | N. of Transactions | Last Quarter |
Showing 1 to 1 of 1 entries
Client Reviews
The Client Reviews provides a qualitative rating based on Partners' Clients feedback assessmentCommunication Skills
Technical skills
Efficiency
Effectiveness
Perceived Added Value
Ranking 2022: Kaixian Zheng - Fangda Partners
| Practice Area | Agg. Deals Value | Clients Dimension | N. of Transactions | Tier |
|---|---|---|---|---|
| Corporate M&A | 4500 | 1258 | 1 |  |
| Practice Area | Agg. Deals Value | Clients Dimension | N. of Transactions | Tier |
Showing 1 to 1 of 1 entries
Ranking 2021: Kaixian Zheng - Fangda Partners
| Practice Area | Agg. Deals Value | Clients Dimension | N. of Transactions | Tier |
|---|---|---|---|---|
| Practice Area | Agg. Deals Value | Clients Dimension | N. of Transactions | Tier |
Ranking 2020: Kaixian Zheng - Fangda Partners
| Practice Area | Agg. Deals Value | Clients Dimension | N. of Transactions | Tier |
|---|---|---|---|---|
| Practice Area | Agg. Deals Value | Clients Dimension | N. of Transactions | Tier |
Significant Clients
The chart shows a balanced list of the Kaixian Zheng's client portfolio - based on PBV Monitor's Analyzed Transactions during last Twelve MounthsTeam
The chart shows a balanced list of counselor working with Kaixian Zheng - based on PBV Monitor's analyzed transactions during last Twelve MounthsCo-Counsel
The Chart shows a balanced list of Kaixian Zheng's Co-Counsel Law Firm - based on PBV Monitor's analyzed transactions during last Twelve MounthsCounterparts
The Chart shows a balanced list of Kaixian Zheng's other Firms involved - based on PBV Monitor's analyzed transactions during last Twelve MounthsPeer Reviews
The Peer Reviews provides a qualitative rating based on Counterparts / Referees' feedback assessmentRecent experiences
QuantumPharm's Shares Offering6/20/2024